Home
Scholarly Works
Real-world utilization and safety of ipilimumab...
Conference

Real-world utilization and safety of ipilimumab plus nivolumab (I plus N) in metastatic renal cell carcinoma (mRCC) patients: Results from the Canadian Kidney Cancer Information System (CKCis)

Authors

Thana M; Basappa NS; Ghosh S; Kollmannsberger CK; Heng DYC; Graham J; Soulieres D; Hansen AR; Lalani A-KA; Castonguay V

Volume

38

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Publication Date

February 20, 2020

Name of conference

Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO)

Conference place

CA, San Francisco

Conference start date

February 13, 2020

Conference end date

February 15, 2020

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

6

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team